Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation

[1]  J. Lieberman,et al.  The Effects of Clozapine on Tardive Dyskinesia , 1991, British Journal of Psychiatry.

[2]  J. Lieberman,et al.  The prevalence of tardive dyskinesia. , 1991, Journal of clinical psychopharmacology.

[3]  Freer Cb.  Care of the elderly. Old myths. , 1985 .

[4]  J. Ross,et al.  DILTIAZEM FOR TARDIVE DYSKINESIA , 1987, The Lancet.

[5]  G. Bagdy,et al.  Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment , 1985, Acta psychiatrica Scandinavica.

[6]  P. Liddle,et al.  Negative Symptoms as a Risk Factor for Tardive Dyskinesia in Schizophrenia , 1993, British Journal of Psychiatry.

[7]  R. Conley,et al.  Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design , 1993, Schizophrenia Research.

[8]  J. Lieberman,et al.  Tardive dyskinesia: prevalence, incidence, and risk factors. , 1988, Psychopharmacology. Supplementum.

[9]  J. Lieberman,et al.  Integrating incidence and prevalence of tardive dyskinesia. , 1986, Psychopharmacology bulletin.

[10]  A J Cross,et al.  Abnormal Involuntary Movements in Schizophrenia: Are They Related to the Disease Process or Its Treatment? Are They Associated with Changes in Dopamine Receptors? , 1982, Journal of clinical psychopharmacology.

[11]  T. Crow,et al.  Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.

[12]  D. Jeste,et al.  ALPHA-TOCOPHEROL IN TARDIVE DYSKINESIA , 1987, The Lancet.

[13]  D. Charney,et al.  The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia , 1989, Biological Psychiatry.

[14]  Alogia, attentional impairment, and inappropriate affect: Their status in the dimensions of schizophrenia , 1993 .

[15]  D. Tarsy,et al.  Withdrawal syndromes associated with antipsychotic drugs. , 1978, The American journal of psychiatry.

[16]  C. Wise,et al.  PLATELET MONOAMINE OXIDASE AND PLASMA DOPAMINE β-HYDROXYLASE IN TARDIVE DYSKINESIA , 1979, The Lancet.

[17]  D. V. Jeste,et al.  Tardive dyskinesia. , 1993, Schizophrenia bulletin.

[18]  Nagley Mm,et al.  Para-amino-salicylic acid in pulmonary tuberculosis. , 1949, Lancet.

[19]  J. Gerlach,et al.  γ-Acetylenic GABA in Tardive Dyskinesia , 1980 .

[20]  P. Liddle,et al.  Negative Symptoms, Tardive Dyskinesia and Depression in Chronic Schizophrenia , 1989, British Journal of Psychiatry.

[21]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[22]  J. Kane,et al.  Research diagnoses for tardive dyskinesia. , 1982, Archives of general psychiatry.

[23]  Schen Rj.  Letter: Chlorpropamide hypoglycaemia. , 1973 .

[24]  N. Andreasen,et al.  Effect of Antipsychotic Withdrawal on Negative Symptoms in Schizophrenia , 1994, Neuropsychopharmacology.